9:41
xvivogroup.com
Screenshot of xvivogroup.com
xvivogroup.com favicon

xvivogroup.com

17 technologies
VerifiedGrowingVisit10.5K/mo$39M25017 Tech25 Leads
Deep Dive

XVIVO: The Organ Lifesaver

A deep dive into the biotech company making cold storage obsolete.

XVIVO isn't just a medical device company; it's a race against the biological clock. While transplant teams wait for viable organs, XVIVO is rewriting the rules of preservation with machine perfusion technologies that keep kidneys, livers, and lungs 'alive' outside the body.

$38.8M
Annual Revenue
250
Employees
32%
Organic Search Traffic
10.5K
Monthly Visits

"XVIVO is transforming 'cold static storage' into dynamic, life-sustaining perfusion. The future of transplantation isn't just about finding a match—it's about keeping the organ viable until you do."

The Market Pulse

With a revenue of $38.8M and a lean team of 250, XVIVO is operating in a high-stakes, high-reward niche. Their organic search traffic (32%) suggests strong brand authority in a sector where trust is paramount. The keywords driving traffic—'liver assist device' and 'kidney assist device'—reveal a market actively seeking alternatives to traditional cold storage.

The Stakeholder Ecosystem

XVIVO’s leadership roster reads like a blueprint for biotech success: Christoffer Rosenblad (CEO), Andreas Wallinder (CMO), and Rob Baumann (VP Commercial, North America). This mix of clinical and commercial expertise suggests a company poised for expansion, not just R&D. Their focus on 'business ethics' and 'careers' pages signals a mature corporate structure ready for enterprise-level partnerships.

The biotech landscape is crowded, but XVIVO distinguishes itself by solving the logistical nightmare of organ transport. While competitors focus on diagnostics or pharmaceuticals, XVIVO owns the supply chain—the 'time' factor in transplantation. This isn't just hardware; it's a platform for extending the viability of human tissue, a critical bottleneck in modern medicine.

  • Specialized in machine perfusion for kidneys, livers, and lungs.
  • Revenue stability at $38.8M with a focused team of 250.
  • Strong North American commercial strategy led by Rob Baumann.
  • Traffic leans heavily on branded and high-intent keywords (e.g., 'XVIVO Milano').
Does not rely on broad, generic traffic (only 10.5K visits).
Focuses on high-value B2B/B2G medical sales cycles.
Avoids mass-market consumer products.
Dominates specific search intent for 'organ assist devices'.

The Verdict: A High-Stakes Play

XVIVO is a capital-efficient biotech with a clear, life-saving mandate. For investors, it represents a bet on the inevitability of organ perfusion technology replacing static storage.

What tech stack does Xvivogroup use?

23 detected
Programming Languages1
Privacy & Consent1
Performance1
Web Standards2
UI Libraries1
JavaScript Libraries2
Tracking & Analytics6
G
Google Analytics
G
Google Tag Manager
G
Google Static
G
Google Tag Manager
G
Google Analytics
L
LinkedIn

How much traffic does Xvivogroup get?

Traffic & Engagement

10.5K
Monthly Visits
1.6
Pages/Visit
0:17
Avg. Duration
41%
Bounce Rate
Monthly Traffic Trend+25%
8.4K
Oct 2025
Oct
5.1K
Nov 2025
Nov
10.5K
Dec 2025
Dec

Traffic Sources

Search
32%
Direct
34%
Social
25%
Referrals
7%
Email
0%
Paid
1%

Where is Xvivogroup's audience located?

🌍47.6%
🌍27.8%
🌍9.7%
🌍6.6%
🌍4.9%

What keywords does Xvivogroup rank for?

5 keywords
1liver assist device230 vol
2liver assist device fda230 vol
3xvivo lifesaving vs life-saving110 vol
4xvivo milano200 vol
5kidney assist device170 vol

How is Xvivogroup's SEO?

Meta Tags

title56 chars

Saving organs so transplant teams can save lives | XVIVO

description146 chars

Machine perfusion technologies for kidneys, livers, and lungs, a solution for cold static storage of lungs, organ recovery and perfusion services.

languageEN-US

H1 Tags

h1Saving organs so transplant teams can save lives

Schema Types

Unknown

Who works at Xvivogroup?

Loading leads...

What do customers think of Xvivogroup?

No Trustpilot reviews available for this company.

Frequently Asked Questions about Xvivogroup

What is Xvivogroup's Revenue?
Xvivogroup generates approximately $39M in annual revenue. With 250 employees, that's $155,000 per employee.
What does Xvivogroup do?
Machine perfusion technologies for kidneys, livers, and lungs, a solution for cold static storage of lungs, organ recovery and perfusion services.
How fast is Xvivogroup growing?
Xvivogroup employee count has changed by 29% year over year.
What technologies does Xvivogroup use?
Xvivogroup uses 17 technologies across their website including Fonts, Security, Programming Languages. Key technologies include Font Awesome, Google Fonts, HSTS, reCAPTCHA, PHP.
Who are Xvivogroup's competitors?
Xvivogroup's main competitors include XVIVO Perfusion AB, BioGaia Probiotics, XVIVO, Ribocure Pharmaceuticals AB, BioLamina AB. These companies operate in similar markets and compete for the same customer base.

Export Data

Unlock all exports

Download CSVs, JSONs & full reports

How to contact Xvivogroup?

What are Xvivogroup's key pages?

Export xvivogroup.com Data

Download the complete tech stack, analytics, leads, and company data for xvivogroup.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.

Raw JSON Data

Click "Show" to view the raw API response data

About xvivogroup.com

Machine perfusion technologies for kidneys, livers, and lungs, a solution for cold static storage of lungs, organ recovery and perfusion services.

Company Overview

xvivogroup.com
Website
#2,245,059
Global Rank
10.5K
Monthly Visitors
17
Technologies
25+
Employees

xvivogroup.com Key Pages

xvivogroup.com Social Media

Contact xvivogroup.com

Technology Stack

xvivogroup.com uses 17 technologies across their website including Font Awesome, Google Fonts, HSTS, reCAPTCHA, PHP, and more.

Fonts

Font Awesome, Google Fonts

Security

HSTS, reCAPTCHA

Programming Languages

PHP

CMS

WordPress

Privacy & Consent

Complianz

Analytics & Marketing

Google Tag Manager, Google Analytics

Traffic & Audience

10.5K
Monthly Visits
41%
Bounce Rate
1.6
Pages/Visit
0:17
Avg. Duration

xvivogroup.com receives approximately 10.5K monthly visitors and ranks #2,245,059 globally. The website has a bounce rate of 41% with visitors viewing an average of 1.6 pages per visit. Users spend an average of 0:17 on the site.

The majority of xvivogroup.com's traffic comes from undefined, undefined, .

Frequently Asked Questions

What is xvivogroup.com?
Machine perfusion technologies for kidneys, livers, and lungs, a solution for cold static storage of lungs, organ recovery and perfusion services.
What technologies does xvivogroup.com use?
xvivogroup.com uses 17 technologies including Font Awesome, Google Fonts, HSTS, reCAPTCHA, and 11 more. View the full tech stack analysis above.
How do I contact xvivogroup.com?
You can contact xvivogroup.com via email at [email protected] or through their contact page.
What are xvivogroup.com's social media accounts?
xvivogroup.com is active on twitter, linkedin. You can find links to all their social media profiles in the social section above.
Is xvivogroup.com hiring?
Check xvivogroup.com's careers page for current job openings and opportunities. The company has 25+ known employees.
How popular is xvivogroup.com?
xvivogroup.com receives approximately 10.5K monthly visitors and ranks #2,245,059 globally. Traffic is growing by 103.2% month-over-month.

Related Searches

xvivogroup.com pricingxvivogroup.com reviewsxvivogroup.com alternativesxvivogroup.com loginxvivogroup.com careerswhat is xvivogroup.comxvivogroup.com tech stackxvivogroup.com contactxvivogroup.com vs competitorsxvivogroup.com featureshow to use xvivogroup.comxvivogroup.com integrations

This page provides publicly available information about xvivogroup.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit xvivogroup.com directly at https://xvivogroup.com.